Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Industry sector: Medical
Sector classification: Pharmaceutical preparations
Deep Learning based analysis and prediction model for Abbott Laboratories (ABT) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since April 29, 2015.
Market data for ABT model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for ABT.
Model is being retrained on a daily basis.
|% Held by Insiders||0.74%|
|% Held by Institutions||72.27%|
|EPS (last reported FY)||$2.50|
|EPS (last reported Q)||$0.59|
|EPS, estimated (last reported Q)||$0.58|
|Total revenues||$27 B|
|Net income||$0 B|